27.09.2023 - Two prospective, peer reviewed trials demonstrate the symptomatic benefit of gammaCore in patients with PTSDROCKAWAY, N.J., Sept. 27, 2023 (GLOBE NEWSWIRE) - electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness . Seite 1
Preliminary results suggest transcutaneous cervical vagus nerve stimulation (tcVNS) improves attention and working memory in patients with post-traumatic stress disorder.